Clinical Trial to Investigate the Efficacy and Safety of NuSepin ® in COVID-19 Pneumonia Patients

Conditions:   Covid19;   Pneumonia Interventions:   Drug: NuSepin® 0.1 mg;   Drug: NuSepin® 0.2 mg;   Drug: Placebo Sponsor:   Shaperon Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials